EOM Pharmaceuticals Holdings, Inc. (IMUC)

IMUC Financials Overview

Financials in millions USD. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Operating Income Operating Income Growth	-2.57	-2.61	-1.94
Net Income Net Income Growth	-5.13	-5.15	-1.94
Earnings Per Share EPS Growth	-0.05	-0.11	-0.04
EPS Growth	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Investments Cash & Investments Growth	0.55	1.49	0.26
Total Debt Total Debt Growth	3.05	2.82	-
Net Cash (Debt) Net Cash Growth	-2.5	-1.33	0.26
Net Cash Growth	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-0.03	-0.03	0.01

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Operating Cash Flow Operating Cash Flow Growth	-2.79	-2.31	-1.65
Free Cash Flow Free Cash Flow Growth	-2.79	-2.31	-1.65
Free Cash Flow Growth	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2022

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error